Metformin and reduced risk of cancer in diabetic patients

2.1kCitations
Citations of this article
784Readers
Mendeley users who have this article in their library.

References Powered by Scopus

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

1155Citations
N/AReaders
Get full text

Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003.

575Citations
N/AReaders
Get full text

The diabetes audit and research in Tayside Scotland (darts) study: Electronic record linkage to create a diabetes register

280Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Understanding the warburg effect: The metabolic requirements of cell proliferation

12511Citations
N/AReaders
Get full text

Fundamentals of cancer metabolism

2127Citations
N/AReaders
Get full text

Insulin and insulin-like growth factor signalling in neoplasia

1764Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005). Metformin and reduced risk of cancer in diabetic patients. British Medical Journal, 330(7503), 1304–1305. https://doi.org/10.1136/bmj.38415.708634.F7

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 273

61%

Researcher 104

23%

Professor / Associate Prof. 57

13%

Lecturer / Post doc 15

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 180

38%

Biochemistry, Genetics and Molecular Bi... 134

28%

Agricultural and Biological Sciences 118

25%

Pharmacology, Toxicology and Pharmaceut... 42

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 2
News Mentions: 5
References: 3
Social Media
Shares, Likes & Comments: 31

Save time finding and organizing research with Mendeley

Sign up for free